PRESS RELEASE published on 06/17/2024 at 07:00, 9 months 23 days ago Inside Information / Other news releases Innate Pharma shares updated results from the Sanofi developed blood cancer Phase 1/2 SAR443579/IPH6101 trial, showing promising clinical efficacy and safety in patients with R/R AML Sanofi Innate Pharma Blood Cancer NK Cell Engager Phase 1/2 Trial
BRIEF published on 05/28/2024 at 07:05, 10 months 13 days ago Innate Pharma announces its participation in upcoming investor conferences Biotechnology Investor Conferences Immunotherapy Health Innate Pharma
BRIEF published on 05/23/2024 at 22:05, 10 months 18 days ago Results of the Combined General Meeting of Innate Pharma Voting Results Supervisory Board General Assembly Innate Pharma
PRESS RELEASE published on 05/23/2024 at 22:00, 10 months 18 days ago Inside Information / Other news releases Innate Pharma announces the voting results of its 2024 AGM. Quorum at 44.92%. Re-election of two Supervisory Board members. Details available on company's website Voting Results Supervisory Board Quorum 2024 AGM Innate Pharma
BRIEF published on 05/21/2024 at 07:05, 10 months 20 days ago Clarification on the status of SAR443579 treatment by Innate Pharma FDA Sanofi Innate Pharma SAR443579 Fast Track
Published on 04/11/2025 at 02:40, 4 hours ago McFarlane Lake Announces Closing of Final Tranche of Upsized $1.3 Million Private Placement Offering
Published on 04/11/2025 at 02:00, 4 hours 40 minutes ago Battery X Metals Announces Formation of Critical Battery Metals Exploration Subsidiary and Expansion of Quebec Exploration Portfolio with Acquisition of 39 Additional Mineral Claims
Published on 04/11/2025 at 00:00, 6 hours 40 minutes ago Onco-Innovations’ Inka Health Publishes Roche-Sponsored Study Advancing Real-World Oncology Research
Published on 04/10/2025 at 23:00, 7 hours 40 minutes ago Highlander Silver Receives Conditional Approval to List on the TSX, Files Base Shelf Prospectus and Establishes ATM Program as Longer Term Financial Alternatives
Published on 04/11/2025 at 06:30, 10 minutes ago R&S Group’s Board of Directors implements succession plan as CEO Markus Laesser decided to step down and announces changes to its Board of Direc-tors
Published on 04/11/2025 at 06:00, 40 minutes ago Sales for the first quarter 2025 Ad hoc announcement pursuant to Art. 53 LR
Published on 04/11/2025 at 05:00, 1 hour 40 minutes ago LISA with Leading Thai and International Artists Captivate the World at the Amazing Thailand Countdown 2025, Reinforcing ICONSIAM as the Ultimate Global Countdown Destination
Published on 04/10/2025 at 20:47, 9 hours 53 minutes ago EQS-Adhoc: Hinkel & Cie. GmbH: first creditors´meeting of the bond DE000A2AAPX4
Published on 04/10/2025 at 17:45, 12 hours 55 minutes ago EURAZEO INVESTS IN EKOSCAN INTEGRITY, A LEADING GLOBAL PROVIDER OF ADVANCED NON-DESTRUCTIVE TESTING SOLUTIONS FOR CRITICAL INDUSTRIAL APPLICATIONS AND INFRASTRUCTURE
Published on 04/09/2025 at 18:59, 1 day 11 hours ago Description of the 2025-2026 Share Buyback Program
Published on 04/09/2025 at 18:57, 1 day 11 hours ago Minutes of the Combined General Meeting held on April 9, 2025
Published on 04/09/2025 at 17:45, 1 day 12 hours ago COGELEC : 2024 full-year results and Q1 2025 revenue.
